Low-Molecular-Weight Heparin as a Bridging Anticoagulant Early After Mechanical Heart Valve Replacement

200679 citationsJournal Articlebronze Open Access

Authors

Philippe Meurin · Centre de Réadaptation Cardiaque Les Grands Prés

Jean Yves Tabet · Centre de Réadaptation Cardiaque Les Grands Prés

Hélène Weber · Centre de Réadaptation Cardiaque Les Grands Prés

Nathalie Renaud · Centre de Réadaptation Cardiaque Les Grands Prés

Ahmed Ben Driss · Centre de Réadaptation Cardiaque Les Grands Prés

Abstract

After MHVR, one third of patients leave the cardiac surgery unit before VKA treatment is fully effective. Bridging anticoagulation therapy with enoxaparin appears to be feasible during this high-risk period for thromboembolism and could shorten the length of hospital stay.

Topics & Keywords

Cardiac Valve Diseases and Treatments Infective Endocarditis Diagnosis and Management Atrial Fibrillation Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 113, Issue 4, pp. 564-569

DOI: 10.1161/circulationaha.105.575571

Field-Weighted Citation Impact: 5.27